New Requirement - Steritest Symbio ISL 2

The contract titled "New Requirement - Steritest Symbio ISL 2" is a forecast opportunity issued by the Food and Drug Administration (FDA) with a posted date of March 11, 2026. It pertains to the acquisition of the Steritest Symbio ISL 2, which falls under the NAICS code 334516, indicating it involves manufacturing or supplying instruments and related products. Specific details such as the solicitation number, type of set-aside, and precise location for performance are not provided, suggesting this is an early notice rather than an active request for proposals. The contract’s points of contact include an acquisition liaison with a designated email and a contracting officer position that is yet to be filled. The FDA oversees this procurement, implying the product relates to healthcare, regulatory compliance, or laboratory testing services. Interested parties are directed to the FDA's forecast link for more information and formal opportunities once available. The absence of detailed location or contact information reflects that this is a preliminary forecast rather than a concluded or active contract.